These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 8161982)

  • 41. Health status versus utilities of patients with end-stage liver disease.
    Bryce CL; Angus DC; Switala J; Roberts MS; Tsevat J
    Qual Life Res; 2004 May; 13(4):773-82. PubMed ID: 15129887
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Developing preference-based measures for diabetes: DHP-3D and DHP-5D.
    Mulhern B; Labeit A; Rowen D; Knowles E; Meadows K; Elliott J; Brazier J
    Diabet Med; 2017 Sep; 34(9):1264-1275. PubMed ID: 28477411
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The relationship of medical, demographic and psychosocial factors to direct and indirect health utility instruments in rheumatoid arthritis.
    Witney AG; Treharne GJ; Tavakoli M; Lyons AC; Vincent K; Scott DL; Kitas GD
    Rheumatology (Oxford); 2006 Aug; 45(8):975-81. PubMed ID: 16461437
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Health related utility measurement in rheumatology: an introduction.
    Bakker CH; Rutten-van Mölken M; van Doorslaer E; Bennett K; van der Linden S
    Patient Educ Couns; 1993 May; 20(2-3):145-52. PubMed ID: 8337191
    [TBL] [Abstract][Full Text] [Related]  

  • 45. What were they thinking when providing preference measurements for generic health states? The evidence for HUI3.
    Feeny D; Furlong W; Torrance GW
    Health Qual Life Outcomes; 2018 Aug; 16(1):166. PubMed ID: 30111316
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cognitive impairment and preferences for current health.
    King JT; Tsevat J; Roberts MS
    Health Qual Life Outcomes; 2009 Jan; 7():1. PubMed ID: 19134191
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Utility values in the visually impaired: comparing time-trade off and VisQoL.
    Gothwal VK; Bagga DK
    Optom Vis Sci; 2013 Aug; 90(8):843-54. PubMed ID: 23628757
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Utility measures of health-related quality of life in patients treated for benign paroxysmal positional vertigo.
    Roberts RA; Abrams H; Sembach MK; Lister JJ; Gans RE; Chisolm TH
    Ear Hear; 2009 Jun; 30(3):369-76. PubMed ID: 19322083
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Assessing health utilities in schizophrenia. A feasibility study.
    Voruganti LN; Awad AG; Oyewumi LK; Cortese L; Zirul S; Dhawan R
    Pharmacoeconomics; 2000 Mar; 17(3):273-86. PubMed ID: 10947302
    [TBL] [Abstract][Full Text] [Related]  

  • 50. An investigation into the empirical validity of the EQ-5D and SF-6D based on hypothetical preferences in a general population.
    Petrou S; Hockley C
    Health Econ; 2005 Nov; 14(11):1169-89. PubMed ID: 15942981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Health values of patients with chronic hepatitis C infection.
    Sherman KE; Sherman SN; Chenier T; Tsevat J
    Arch Intern Med; 2004 Nov; 164(21):2377-82. PubMed ID: 15557419
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of preference-based utilities of the Short-Form 36 Health Survey and Health Utilities Index before and after treatment of patients with intermittent claudication.
    Bosch JL; Halpern EF; Gazelle GS
    Med Decis Making; 2002; 22(5):403-9. PubMed ID: 12365482
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Comparing and explaining differences in the magnitude, content, and sensitivity of utilities predicted by the EQ-5D, SF-6D, HUI 3, 15D, QWB, and AQoL-8D multiattribute utility instruments.
    Richardson J; Khan MA; Iezzi A; Maxwell A
    Med Decis Making; 2015 Apr; 35(3):276-91. PubMed ID: 25159172
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Deriving a Preference-Based Measure for Myelofibrosis from the EORTC QLQ-C30 and the MF-SAF.
    Mukuria C; Rowen D; Brazier JE; Young TA; Nafees B
    Value Health; 2015 Sep; 18(6):846-55. PubMed ID: 26409613
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A framework for estimating health state utility values within a discrete choice experiment: modeling risky choices.
    Robinson A; Spencer A; Moffatt P
    Med Decis Making; 2015 Apr; 35(3):341-50. PubMed ID: 25349189
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Change in clinical status, health status, and health utility outcomes in HIV-infected patients.
    Revicki DA; Wu AW; Murray MI
    Med Care; 1995 Apr; 33(4 Suppl):AS173-82. PubMed ID: 7723445
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Vision and quality-of-life.
    Brown GC
    Trans Am Ophthalmol Soc; 1999; 97():473-511. PubMed ID: 10703139
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship between quality of life instruments, health state utilities, and willingness to pay in patients with asthma.
    Blumenschein K; Johannesson M
    Ann Allergy Asthma Immunol; 1998 Feb; 80(2):189-94. PubMed ID: 9494453
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Outcomes of social care for adults: developing a preference-weighted measure.
    Netten A; Burge P; Malley J; Potoglou D; Towers AM; Brazier J; Flynn T; Forder J; Wall B
    Health Technol Assess; 2012; 16(16):1-166. PubMed ID: 22459668
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessing utility values in rheumatoid arthritis: a comparison between time trade-off and the EuroQol.
    Ariza-Ariza R; Hernández-Cruz B; Carmona L; Dolores Ruiz-Montesinos M; Ballina J; Navarro-Sarabia F;
    Arthritis Rheum; 2006 Oct; 55(5):751-6. PubMed ID: 17013822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.